Bill Ferris | |
---|---|
Chairman of the Australian Trade Commission | |
In office 1986 –17 December 1993 | |
Preceded by | Office created |
Succeeded by | Robert Johnston |
Personal details | |
Born | William Duncan Ferris Sydney,New South Wales,Australia |
Alma mater | University of Sydney Harvard Business School |
Occupation | Philanthropist,entrepreneur,executive |
Known for | Founding the Ferris Foundation,support for the arts and culture in Australia |
William Duncan Ferris AC is an Australian philanthropist and entrepreneur. He is the founder of the Ferris Foundation,which supports the arts and culture in Australia,and he is the author of three books. He was appointed a Companion of the Order of Australia (AC) for service to the community through a range of philanthropic endeavours.
Ferris holds an Honours degree in economics from the University of Sydney and a Master of Business Administration from Harvard Business School where he graduated as a Baker Scholar in 1970. [1]
Ferris has served several major organizations throughout his career. He served as a director on the boards of several companies,including Qantas,BHP,the Commonwealth Bank,Accolade Wines Australia and UK,Austar,Macquarie University Asia Pacific Council,Austal and the Australian Institute of Management [2] [1] ,Brandon BioCatalyst and AdvanCell Pty Ltd.
Ferris founded Australia's first venture capital firm in 1970. He co-founded Australian Mezzanine Investments in 1987 with Joseph Skrzynski. [2] [1] In 1999,he teamed with Skrzynski again and Castle Harlan to create Castle Harlan Australian Mezzanine Partners,also known as CHAMP,which became a leading private equity firm in the Asia-Pacific region. CHAMP (now known as CPE Capital) focuses on control investments in middle-market businesses in Australia and Southeast Asia. CHAMP raised its second fund with A$950 million of investor commitments in 2005 and its third fund with A$1.5 billion in 2010. [3]
He also served a number of professional and community organizations including the Garvan Insitute of Medical Research,from 2000 to 2012. He was inaugural chair of the Australian Trade Commission (Austrade),stepping down in 1993 "after almost a decade". [4] He served as an expert on the Federal Government's Strategic Review of Health and Medical Research in 2011. He was chair of the Australian government's Innovation and Science Australia entity in 2015 [5] [6] Other roles have included a Member of the Harvard Business School Asia Pacific Advisory Council,and Chair of the Federal Government's Health and Hospitals Fund Advisory Board. [1]
Ferris is known for his philanthropic work through the Ferris Foundation. He founded the Ferris Foundation in 1981,which has since become one of the larger philanthropic organizations in Australia.[ citation needed ] The foundation supports various initiatives,including the arts and cultural programs,environmental conservation,medical research and education.
Ferris has also personally served many organizations. He became the Chair of the Medical Research Commercialisation Fund in 2020. [7] [1] This is a government fund that "will provide $450 million over 10 years from 2022-23 to support innovative early stage health and medical research in Australia". [8] He was Chair of the Garvan Institute of Medical Research and inaugural chair of the government's Innovation and Science Australia Board. [7]
Ferris has also been recognized for his contributions to and made Companion of Australia for venture capital and private equity and philanthropic support of medical research.[ citation needed ] He was made an Officer of the Order of Australia in 1990 for services to the export industry. [9] The same year, he was Entrepreneur Champion in the Ernst & Young Entrepreneur of the Year Award. In 2008 he received the first Asian Venture Capital Journal Lifetime Achievement Award, and also the first AVCAL Lifetime Contribution Award. In 2014 he was awarded the "Leader of the Year, Asia-Pacific", in the Private Equity International Awards. [1]
In the 2008 Australia Day Honours List, he was elevated to a Companion of the Order of Australia (AC) "for service to the community through a range of philanthropic endeavours, as a leader in support of medical research, and to business and commerce through ongoing roles supporting Australian exports, venture capital and private equity." [10]
Philanthropy is a form of altruism that consists of "private initiatives for the public good, focusing on quality of life". Philanthropy contrasts with business initiatives, which are private initiatives for private good, focusing on material gain; and with government endeavors that are public initiatives for public good, such as those that focus on the provision of public services. A person who practices philanthropy is a philanthropist.
The Rockefeller Foundation is an American private foundation and philanthropic medical research and arts funding organization based at 420 Fifth Avenue, New York City. The foundation was created by Standard Oil magnate John D. Rockefeller ("Senior") and son "Junior", and their primary business advisor, Frederick Taylor Gates, on May 14, 1913, when its charter was granted by New York. It is the second-oldest major philanthropic institution in America and ranks as the 30th largest foundation globally by endowment, with assets of over $6.3 billion in 2022. According to the OECD, the foundation provided $284 million for development in 2021. The foundation has given more than $14 billion in current dollars.
Venture capital (VC) is a form of private equity financing provided by firms or funds to startup, early-stage, and emerging companies, that have been deemed to have high growth potential or that have demonstrated high growth in terms of number of employees, annual revenue, scale of operations, etc. Venture capital firms or funds invest in these early-stage companies in exchange for equity, or an ownership stake. Venture capitalists take on the risk of financing start-ups in the hopes that some of the companies they support will become successful. Because startups face high uncertainty, VC investments have high rates of failure. Start-ups are usually based on an innovative technology or business model and often come from high technology industries such as information technology (IT) or biotechnology.
Sir Ka-shing Li is a Hong Kong billionaire business magnate, investor, and philanthropist. He is the senior advisor for CK Hutchison Holdings and CK Asset Holdings, after he retired from the Chairman of the Board in May 2018; through it, he is a port investor, developer, and operator of the largest health and beauty retailer in Asia and Europe. As of July 2023, Li is the 33rd richest person in the world, with an estimated net wealth of US$37.7 billion.
Funding is the act of providing resources to finance a need, program, or project. While this is usually in the form of money, it can also take the form of effort or time from an organization or company. Generally, this word is used when a firm uses its internal reserves to satisfy its necessity for cash, while the term financing is used when the firm acquires capital from external sources.
A business incubator is an organization that helps startup companies and individual entrepreneurs to develop their businesses by providing a fullscale range of services, starting with management training and office space, and ending with venture capital financing. The National Business Incubation Association (NBIA) defines business incubators as a catalyst tool for either regional or national economic development. NBIA categorizes its members' incubators by the following five incubator types: academic institutions; non-profit development corporations; for-profit property development ventures; venture capital firms, and a combination of the above.
Joseph Louis Rotman was a Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of organizations such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.
Ronald Crawford Conway is an American venture capitalist and philanthropist. He has been described as one of Silicon Valley's "super angels".
The National Health and Medical Research Council (NHMRC) is the main statutory authority of the Australian Government responsible for medical research. It was the eighth largest research funding body in the world in 2016, and NHMRC-funded research is globally recognised for its high quality. Around 45% of all Australian medical research from 2008–12 was funded by the federal government, through the NHMRC.
Sir David James Scott Cooksey was a British businessman, venture capitalist and policy advisor.
Senapathy “Kris” Gopalakrishnan is an Indian businessman and the chairman of Axilor Ventures, a startup accelerator. He is one of the co-founders of Infosys, having served as its CEO and managing director from 2007 to 2011 and vice chairman from 2011 to 2014.
Jeremy Coller is a British businessman and philanthropist. He is the founder, chief investment officer and chairman of Coller Capital.
Castle Harlan is a private equity firm based in New York City. The company focuses on buyouts and growth capital investments in middle-market companies across a range of industries. Founded in 1987, Castle Harlan invests in controlling interests in middle-market companies in North America and Europe, Australia and Southeast Asia through Castle Harlan Australian Mezzanine Partners.
Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.
Phil Hagerman is an American entrepreneur, philanthropist, pharmacist and former CEO and chairman of Diplomat Pharmacy, Inc. Diplomat was the largest independent provider of specialty pharmacy services in the United States until its sale to Optum/United Health in February 2020 He co-founded Diplomat Pharmacy, Inc. in 1975 with his father, Dale Hagerman, and its stock was sold on the New York Stock Exchange (NYSE) starting in October 2014.
Philip M. Bilden is an American businessman and private equity & venture capital investor. He was nominated by President Donald Trump to serve as the 76th United States Secretary of the Navy in January, 2017, although he subsequently withdrew himself from consideration. He is a philanthropist and advocate for national security, the U.S. Navy, and cybersecurity.
Dr. Ruth Mitchell McKernan is a British neuroscientist known for her work on ligand-gated ion channels, and for services to business and innovation for which she was appointed CBE in 2013. She is a founding director of Astronautx, a start-up researching dementia treatments targeting astrocytes.
Judith Ann Whitworth is an Australian medical researcher in the areas of kidney function and blood pressure. Now an emeritus professor, she is the former director of the John Curtin School of Medical Research and Howard Florey Professor of Medical Research at the Australian National University (ANU).
Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. As of May 2024, he is the deputy directory and Laboratory Head of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."
Douglas J. Cumming is a Canadian financial economist. He is the DeSantis Distinguished Professor and chair of the finance department in the College of Business at Florida Atlantic University in the United States.
Subscription
In recognition of service to international trade and to industry